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Abstract: Microbial metabolomics constitutes an integrated component of systems biology. By studying the complete set 
of metabolites within a microorganism and monitoring the global outcome of interactions between its development 
processes and the environment, metabolomics can potentially provide a more accurate snap shot of the actual 
physiological state of the cell. Recent advancement of technologies and post-genomic developments enable the study and 
analysis of metabolome. This unique contribution resulted in many scientific disciplines incorporating metabolomics as 
one of their “omics” platforms. This review focuses on metabolomics in microorganisms and utilizes selected topics to 
illustrate its impact on the understanding of systems microbiology. 
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INTRODUCTION 
  This past February marks the 10
th anniversary of the 
unveiling of human genome sequences – a momentous 
milestone that made headlines around the world [1]. 
Described as the “crowning achievement in biology”, among 
the contributions that made this exceptional accomplishment 
possible was the microbial genome sequencing effort that 
took place years prior. In 1995, the first complete genome 
sequences of a free living bacterium, Haemophilus in-
fluenzae, were published [2]. Since then, new generations of 
sequencing technologies have allowed genome sequences to 
be completed from a variety of organisms. At the time of 
writing this review, genomes from over 1,600 prokaryotes 
representing different phylogenetic groups in both Domains 
of the Archaea and the Bacteria have been completed and 
deposited in Genbank [3]. Moreover, the Joint Genome 
Institute has released over 500 completed microbial genomes 
as of July 2011 [4].  
  Ushering in the genomic era witnessed an unprecedented 
capability to assess cellular information and network 
interactions, thus expanding knowledge from individual cell 
to global biological systems. Transcriptomics and 
proteomics came on the scene shortly after genomics to 
allow comprehensive cellular assessments at the 
transcription and translation level. More “omics” followed 
and in the process a number of high-throughput and 
powerful analytical methods were developed. These are 
instrumental in the fruition of metabolomics – an important 
complement to assess genetic function [5-7].  
  The study of metabolome – the complete set of 
metabolites produced within an organism – is a reflection of 
enzymatic pathways and networks encoded within the 
genome. Additionally, the entire composition of metabolites  
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conveys the interplay of developmental processes and a 
changing environment over the lifetime of an organism. By 
monitoring the global outcome of various factors acting on 
the cell, metabolomics can potentially provide a more 
accurate snap shot of the actual physiological state of the 
organism [8-10]. 
  The monitoring of metabolite components in a system 
(i.e., metabolite profiling) can be traced back to ancient 
cultures. For incidence, doctors noted the change in patient’s 
body fluids (e.g., saliva, urine) to diagnose an illness [5, 10]. 
As analytical technologies became available in recent years, 
many metabolites were identified as biomarkers for diseases 
and examples include coronary heart disease, mental 
disorders, cancer and diabetes [5, 11-13]. Other health-
related areas that have capitalized on metabolomics include 
toxicology, nutrition (nutrigenomics), in vitro fertilization 
and oncology, to name just a few [10, 14-16]. 
  The plant sciences community has also been active in 
metabolomics research. The high sensitivity of detection 
afforded by metabolome analyses allowed studies in several 
areas; such as the differentiation of wild-types from 
transgenic counterparts in fruits and vegetables, specific 
chemical detections in medicinal plants, metabolic network 
reconstructions, as well as compound formation and 
monitoring in transgenic vegetables [17-21]. 
  The increased interest in metabolomics and continuous 
broadening of its applications are evident from a surge of 
publications in this field since 2003 [14]. It is believed that 
the time has come to initiate this integrated phase of systems 
biology, bringing together previous and more traditional 
“bottom-up” approach of gathering cellular information from 
individual biological organization and its regulation (i.e., 
genomics, transciptomics, and proteomics) [7]. As the 
metabolic complement of functional genomics, 
metabolomics allow a more complete picture because the 
intermediates of biochemical reactions play a crucial role in 
connecting different pathways operating in a living cell. 
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Collaborations and consortia are already in place to 
comprehensively assess metabolites, provide repository and 
produce databases. The Human Metabolome Project and the 
Consortium for Metabonomic Toxicology (COMET) are 
prime examples [23, 24].  
  By comparison, metabolomics in microorganisms is a 
relatively late comer albeit microbial genomics was at the 
forefront of sequencing technology and prokaryotes lead in 
the numbers of completed sequenced organisms [25]. 
Nevertheless, microbial metabolomics is by no means 
lagging in progress and contribution. This review, therefore, 
attempts to focus on microbial metabolomics and mentions a 
few key areas where considerable interest has been generated 
in the community and significant progress has been made. 
The subjects are generally categorized as the association of 
microbial metabolome with humans, with environmental 
ecosystems, and conclude with metabolomics contribution to 
metabolic pathway reconstruction and analysis.  
  Two terminologies are mentioned in the literature and 
often interchangeably – metabolomics and metabonomics. 
According to Jeremy Nicholson who pioneered the latter 
approach, “the distinction between the two terms is mainly 
philosophical rather than technical” [10]. Therefore, 
“metabolomics” is used throughout this review. 
METABOLOMICS AND ITS CHALLENGES 
  Metabolomics is the study of global metabolite profiles 
of a cell under a given set of conditions. It is an important 
component of systems biology that recognizes as a living 
system, emergent properties cannot be predicted solely by 
individual parts. Instead, biological outcomes require an 
integrated approach to study the sum of all systems [22, 26]. 
As metabolic products reflect the interactions between the 
cell’s genome and its environment, metabolomics provides 
unbiased assessment of a cellular state within the context of 
that particular condition [14, 16]. Since concentrations of 
intracellular metabolites often reveal aspects of biochemical 
regulations that are undetectable by other approaches, 
metabolomics fills in the gaps from the more traditional 
studies of interactions between genes, proteins and 
metabolites in individual cells [27]. It also addresses 
ambiguities resulting from environmental influences on 
cellular expressions. Additionally, metabolite changes often 
result in alterations in phenotype and cellular functions 
which can be followed by analysis of metabolome [6, 16]. 
Metabolomics has already demonstrated its critical role in 
bioenergy, environmental interactions, functional genomics 
and gene discovery, secondary metabolism, genome-wide 
association mapping, and metabolic modeling in higher 
organism and microbial systems [5, 7, 14]. 
  The main challenge of metabolomics is largely technical 
– the ability to identify and quantify the entire set of 
intracellular and extracellular metabolites with molecular 
mass lower than 1,000 daltons [6, 28]. The numbers of these 
compounds vary among different organisms, from hundreds 
to hundreds of thousands and in many cases their identity 
maybe unknown. In contrast to genome, transcriptome and 
proteome analyses, products generated from metabolic 
reactions are highly variable in their chemical structures and 
properties [7]. The metabolome may consist of hydrophilic 
carbohydrates, volatile alcohols, ketones, amino and non-
amino organic acids, hydrophobic lipids and complex natural 
compounds (secondary metabolites such as antibiotics, 
pigments, non-ribosomal peptides, cofactors) [6, 22, 29]. 
This makes simultaneously determining the entire set of 
metabolites at a given physiological state extremely difficult 
[9, 28]. Further complicating the analyses is the dynamic 
nature of these metabolites. Constantly in a state of flux, 
their concentrations and compositions change rapidly in 
response to environmental stimuli [6, 7, 27]. Correlation of 
results may not be straightforward, since a direct link 
between genes and metabolites sometimes does not exist (for 
example, microorganisms have fewer metabolites than 
genes) [27, 30]. All these factors contribute to the 
complexity and difficulty of metabolomics research.  
RECENT DEVELOPMENTS ENABLING THE STUDY 
OF METABOLOMICS 
  Although significant progress has been shown, some 
researchers consider metabolomics to be still in its infancy or 
at an emerging stage [5, 27]. Others advocate the time has 
come to integrate it as one of the important parts of systems 
biology and to offer it a role complementary to genomics and 
proteomics [6, 10, 31-33]. Regardless of various opinions, 
metabolomics has undeniably leveraged on the knowledge 
and experience gained from other “omics”. Significant 
developments in three areas have made the study and 
analyses of metabolome feasible. 
1. Improvement of Analytical Tools 
  The first and perhaps foremost outcome in post-genomic 
era enabling the advancement of metabolomics research is 
the substantial improvement of analytical tools. This was 
initially motivated by the need to screen large number of 
intracellular metabolites in the context of functional 
genomics. Two technologies commonly associated with 
metabolome analyses are nuclear magnetic resonance 
(NMR) spectroscopy and mass spectrometry (MS) [5, 6, 27, 
34, 35]. Both methods are capable of handling a wide range 
of metabolites in a single measurement without the need to 
pre-select specific analytes. Additionally, these technologies 
allow the identification of metabolites’ structures and 
measurement of molecule concentrations [10] As a result, 
these two technologies are the accepted analytical methods 
for metabolomics studies in several scientific disciplines [14, 
16]. 
  NMR was already in use in the 1940’s, but continued 
improvements have greatly increased the sensitivity level to 
enabling the identification of metabolites in biological fluids, 
plant cells, and microbial cells [8, 10, 15, 17, 23]. Since the 
procedure does not require physical or chemical treatments, 
the samples can be recovered afterwards which is an 
attractive feature of this technique. On the other hand, MS is 
more sensitive than NMR [6, 35]. There are many variations 
of MS. The more traditional approach is often coupled to a 
separation technique, such as chromatography-based 
methods, to identify and quantify metabolites with good 
sensitivity and specificity [7, 9, 11, 21, 28, 36]. Newer MS 
technologies include stand-alone instruments that are capable 
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Others utilize surface-based mass analysis with or without 
matrices, and with ultra-high-accuracy mass analyzers in 
order to further increase sensitivity, minimize background 
and reduce sample preparation. Examples mentioned in the 
literature include direct infusion MS, Matrix-Assisted Laser 
Desorption Ionization time of flight (MALDI-TOF), 
Secondary Ion Mass Spectrometry (SIMS), Fourier 
transform ion cyclotron resonance MS and Orbitrap MS [6, 
14, 32, 37].  
  A number of good review articles provide more details 
on the technical aspects of NMR and MS, compare their 
advantages and limitations, and discuss some of their unique 
applications [6, 7, 9, 32, 38]. Therefore, they will not be 
repeated here.  
2. Availability of Genomic Sequences 
  The last decade witnessed a profound increase in 
capability to perform low-cost, high-throughput sequencing. 
From whole-genome shotgun sequencing used in 
deciphering genetic codes of the first bacterium 
Haemophilus influenzae to the dramatic changes in 
automation and massively parallel DNA sequencing in 
recent years, individual genome sequencing is becoming 
common place [2, 39]. 
  Over 1,000 finished prokaryotic genomes are available in 
Entrez Genome and many more are near completion. Diverse 
groups are represented and they include pathogens, 
extremophiles, endosymbionts, gut commensals and 
ecologically important members (e.g., nitrogen fixers, carbon 
fixers) [3]. Some genera are better profiled by the 
availability of genomes from multiple species (e.g., 
Mycobacterium) and in some cases, genomes of several 
strains within a species (e.g., Mycobacterium tuberculosis). 
Because next generation and third generation sequencers 
claim high speed and low cost, producing DNA sequences 
from microorganisms is no longer confined to large genomic 
centers. A plethora of sequencing information is now 
available. This allows comparisons and genome wide 
analyses to be conducted at all levels. This also enables the 
assessment of different and unique attributes of an organism 
within a community as well as detection of its novel 
metabolic pathways [40-42].  
  Following the sequencing of individual microbial 
genomes, the high-throughput capability of sequencing 
technologies makes feasible the next level of systems 
biology – large scale gene assessment of community 
members [43, 44]. Most microbes found in nature exist in 
complex, interdependent communities and cannot be readily 
isolated and grown in the laboratory. Genomic analyses of 
whole communities (i.e., environmental genomics) reveal 
microbial diversity previously unknown. A number of 
metagenomic projects and consortia from bio-diverse 
environments have added billions of base pairs to the 
sequence database [4, 29, 45, 46]. These data are necessary 
to resolve the intricacies of microbial members residing in 
different ecological niches and to understand community 
diversity [41, 42, 47, 48]. The microbial communities 
associated with humans have also been explored by 
metagenomic sequencing. For instance, a whole-genome 
shotgun (WGS) approach was used to define the full genetic 
diversity and predict gene functions of gut microorganisms 
[49]. This paves the way for ecosystems biology to combine 
data generated from metagenomics with those from other 
meta-“omics” in order to reconstruct system-wide networks 
in microbial communities [22, 44, 50-52]. 
3. Data Integration, Standards and Models 
  The organization of the various “omics” in a hierarchical 
fashion enables an integration approach which becomes the 
foundation of systems biology [22, 27]. There are multiple 
benefits but most importantly, integration and correlation of 
data sets provide insights not obtainable from other 
techniques [7, 14]. A number of annotation and statistical 
tools as well as network analysis software and databases 
have been developed [32, 34, 53-55]. Among them, are those 
with metabolomics applicability (e.g., Kyoto Encyclopedia 
of Genes and Genomics, KEGG; Clusters of Orthologous 
Groups, COG; Entrez Gene, Transport DB and UniProtKB) 
[22, 29, 31, 50]. A considerable effort has been initiated to 
establish common interchangeable standards in genomics 
and proteomics in order to successfully integrate data sets 
[25, 33]. Furthermore, new models to address specific 
challenges pose by metabolomics are being developed [7, 
14]. These informatics resources are valuable for 
reconstructing biochemical networks and metabolic 
engineering in different microbes [22, 27, 32, 50, 55].  
  Because informatics is dynamic, it is likely that adaptable 
databases and novel analytical tools will continue to arrive 
on the scene. As more large scale projects take place, they 
will encounter unique challenges when integrating vast 
amount of data generated from various platforms [25, 56, 
57]. Knowledge gleaned from previous efforts can become 
the foundation for future endeavors.  
MICROBIAL METABOLOMICS AND APPLICA-
TIONS 
  Microorganisms are ideal for conducting systems biology 
studies because they are easy to manipulate and have crucial 
roles in human health as well as the biosphere. Microbial 
metabolomics is one of the platforms for integrating 
biological information into systems microbiology to 
facilitate the understanding of microbial interactions and 
cellular functions. 
  As a context-dependent subject reflecting the overall 
physiological state of the cell, the discussion of microbial 
metabolomics cannot be dissociated from its host or 
ecological niche. There are a variety of topics and 
applications reported in the literature. This review focuses on 
three selected areas to illustrate the recent progress of 
microbial metabolomics. 
1. Human Ecosystems  
  The Human Microbiome Project (HMP), initiated in 
2007, represents a paradigm shift in how microbes are being 
viewed in human biology. Until recently, bacteria were 
mostly regarded as intruders that upset the systems which 
they colonized. Although research findings from different 
metagenomics projects pointed to the key roles that microbes 
play, this recognition was mainly confined to environmental 
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  In the last decade, there was an obvious change in the 
perception of interactions between microbes and humans. 
After the completion of the Human Genome Project, it was 
soon realized that microorganisms living inside and on 
humans (i.e., microbiota) are outnumbered human cells by 
an estimated factor of ten [29, 56]. If humans are composites 
of human and microbial cells, the metabolic features of 
humans are a blend of traits from both [58]. Earlier 
metagenomics studies supported this idea that the 
microbiome (i.e., genomes of microbiota), including many 
taxa that were unknown and uncultured, is crucial for human 
health, [40, 59-61].  
  As an extension of the Human Genome Project, the HMP 
provides a great opportunity to integrate complex systems 
that account for microbial community structure (microbiota), 
gene content (metagenomics), gene expression (meta-
transciptomics and meta-proteomics), and metabolism (meta-
metabolomics) [58]. Five sites of the human body were 
surveyed to provide a comprehensive inventory: the mouth, 
the gastrointestinal tract, the vagina, the skin and the nasal 
cavity [56, 58, 62]. Parallel efforts to sequence new 
reference genomes assist the understanding of the microbial 
communities. As of the end of 2010, 500 out of the 3,000 
relevant microbial genomes have been sequenced [59].  
  Significant findings have already resulted from HMP 
since its inception. Among them, gut microbiota will be 
further discussed because this community is perhaps one of 
the best illustrations for the interaction between human and 
microbial metabolomes and a number of papers have been 
published on this topic. This is by no means minimizing the 
contributions of microbial communities associated with other 
human colonization sites; in fact, interesting findings are 
already emerging [60, 62-64].  
Gut Microbiota 
  The microbes (including bacteria, archaea and fungi) 
residing in the gut have long been known as important 
components of the intestinal ecosystem [12, 40, 46]. There 
are approximately 10
14 microorganisms in the human 
intestinal tract comprising more than 1,000 species including 
many that cannot be cultivated [29, 35, 61, 65]. This 
abundant and diverse population of residents, or microbiota, 
offers many benefits. These include defense against 
pathogens, confer immunity, renew gut epithelial cells, 
harvest inaccessible nutrients, and generate energy by 
anaerobic metabolism of substrates [35, 40, 58]. With a 
systems biology approach, host and gut-microbial interaction 
can be visualized from multi-dimensional perspectives.  
a. Metabolize Foreign Substances and Toxins 
  The first report describing the functional attributes of 
microbiome resulted from a metagenomic analysis of fecal 
samples from two unrelated, healthy adults [29, 58]. 
Metabolic function analysis was done by comparing the 
metagenome to previously-sequenced microbial and human 
genomes. A number of genes involved in certain metabolic 
pathways were significantly enriched in the human distal gut 
microbiome, such as those involved in the metabolism of 
foreign substances, glycans (plant polysaccharides), amino 
acids; production of methane (likely as a mechanism to 
remove H2 from bacterial fermentation); and utilization of 
the MEP (2-methyl-D-erythritol 4-phosphate) pathway to 
synthesize vitamins and isoprenoids [29]. 
  The contribution of gut microbiota to the metabolism of 
exotic substances (i.e., xenobiotics) is noteworthy, as most 
drugs are considered foreign to the body. Analogous to 
bioremediation, these microbes can detoxify harmful 
compounds (e.g., carcinogens) which impact the host in a 
variety of ways. These include susceptibility to cancer, 
efficiency of drug metabolism, and absorbing derivatives 
from plants (e.g., flavonoids) [29, 58]. Indeed, a number of 
reports have indicated differences in gut microbiome content 
among populations and geographical variability in microbial-
related drug metabolism [12, 35]. Furthermore, as host and 
microbes have co-existed through the centuries, selective 
pressure resulting in both systems to come up with beneficial 
enzyme systems [66]. One example is co-metabolism which 
not only enhances survival by converting potential harmful 
substances into valuable energy sources, but also expands 
the metabolic repertoire to transform xenobiotics [35, 67].  
  On the other hand, co-metabolism can have an opposite 
effect if the breakdown products are harmful to the host. At 
times, gut residents metabolize toxins or xenobiotics into 
substances that are potentially more unfavorable, such as 
carcinogens, with long term consequences [35].  
  Therefore, a complex continuum and dynamic 
interactions exist between a controlled metabolism of the 
host and the co-metabolism contributed by both the 
microbiota and host. The latter is often fed by exogenous 
sources such as dietary substances and metabolic products 
formed by gut-microbiota. This results in “combinatorial 
metabolism” as termed by Nicholson et al. and further 
complicates the measurement and analysis of metabolites as 
well as their effects on the host [35].  
b. Modulate Human Phenotypes 
  Human phenotypes are affected by microorganisms 
residing in the gut. Earlier studies indicate human 
populations can be distinguished by their gut-microbiota 
which in turn are influenced by a variety of conditions such 
as lifestyles, history, and physiological makeup [58, 68]. 
Among the different factors affecting gut residents is diet. 
The slogan “we are what we eat” has a more profound 
meaning in light of recent findings – the types of food 
ingested actually modify the gut microbiome and thus alter 
host phenotypes [69].  
  An earlier paper by Ley et al. described that diet, host 
morphology, and phylogeny affected the composition of 
vertebrate gut microbiota [66]. The authors compared human 
gut microbiome with those from primates and mammals, and 
followed variations of mammalian gut microorganisms 
through history as a reflection of their ecological niches and 
diet changes. They concluded that the shifts of human diet 
over time influenced human genomes. Two illustrations were 
provided: an increase in salivary amylase gene correlated 
with a high starch diet, and lactose intolerance coincided 
geographically with milk-protein gene diversity in cattle and 
the locations of cattle-farming sites [66, 70]. The latter 
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technology, and cooking style have shaped microbial 
ecology and human microbiome [71].  
  In a more recent report, an association was noted 
between the number of microbial genes involved in certain 
metabolic pathways and the host phenotype. In this case, 
animal studies were conducted to look at obesity. 
Metagenomic analyses indicated that the microbiome in 
obese mice had an increased capability to harvest energy 
from their diets and thus resulted in fat deposition [58, 68]. 
More specifically, the whole genome shotgun (WGS) 
approach used to define the full genetic diversity of and 
functions associated with the gut microbiome showed that 
gene contents was enriched for those involved in importing 
and metabolizing otherwise indigestible polysaccharides to 
short-chain fatty acids. These in turn could be easily 
absorbed and stored as complex lipids in host adipose tissue. 
This was further confirmed in germ-free animals by 
colonizing them with microbiota from obese mice and 
observing a significantly greater increase in total body fat in 
comparison to normal mice [49].  
  Like mice, humans harbor two predominant groups of 
bacteria, namely the Bacterioidetes and the Firmicutes. A 
similar association of human gut microbiota composition 
with obesity was noted and the relative proportion of 
Bacterioidetes was lower in obese people when compared 
with lean individuals. This ratio changed when obese people 
were put on a low calorie diet (carbohydrate-restricted or fat-
restricted) and lost between 2-6 % of their body weight [68]. 
These findings demonstrated that the gut-microbiome plays a 
role in obesity [69].  
  On the other hand, metabolites from the gut microbiota 
can change in spite of constant diet. This may be due to 
changes in how food is metabolized (e.g., using different 
metabolic pathways) or an alteration in gut microbiota 
resulting from other environmental factors (e.g., stress) [35]. 
Background variation obviously complicates the 
interpretation of results generated from host metabolism, 
microbial metabolome, or a combination of both. 
c. As Etiology for a Disease or Condition 
  As part of a complex ecosystem, the gut microbiota 
influences the health status of the host [40, 65, 72]. On the 
beneficial side, in addition to the aforementioned 
contributions to the metabolism of various substances, there 
is evidence that microorganisms promote healthy gut 
development by forming normal villous structures and 
renewing gut epithelial cells [35, 58]. Animals lacking a 
community of microbes in their gut end up with anatomical 
disorders that often predispose them to disease [67, 73].  
  There is a mutualistic relationship between the host and 
its gut microbiota. The environment, host genetics and the 
microbiome all play a part in the homeostasis of the gut [69]. 
Interactions between the microbiota and the host can 
influence disease progression [35, 74]. For some, the 
outcome is positive, resulting in reduced occurrence or 
controlled disease manifestation. One of the mechanisms is 
by microbial interactions with epithelial and immune cells in 
the intestine, such as promoting anti-inflammatory immune 
response by the indigenous gut bacteria and activating 
regulatory cells of the host [74]. A recent paper reported that 
the colonization of germ-free mice with a cocktail of 46 
Clostridium  species was sufficient to induce the 
accumulation of interleukin-10 (IL-10) cells and T regulatory 
cells (Tregs) in the colon [61]. Included in the study was a 
mouse model of colitis that resembled human irritable bowel 
syndrome, and the symptoms were significantly suppressed 
in mice that were colonized with Clostridium species. The 
authors speculated that a diverse set of metabolites produced 
by the 46 strains of Clostridium contributed to maintaining 
immune homeostasis in mice and possibly in humans as well 
[61]. 
  On the other hand, the gut microbial community can 
exert an adverse effect on hosts, resulting in immune 
disorders within and outside of the gut. There is evidence 
that the gut microbiota plays a role in the development and 
activity of both the innate and the adaptive immune systems 
[40, 58]. Irritable bowel syndrome (IBS) and Crohn’s disease 
are perhaps the best known examples of inflammatory 
intestinal diseases resulting from a dysregulated immune 
response to the gut microbial community [58]. The former 
affects 10-20% of world population and evidence indicates 
that intestinal fermentation patterns reflective of microbial 
metabolism were changed in these patients [75]. This was 
confirmed by a genomic study showing significant 
alterations in microbial composition in IBS patients when 
compared to healthy individuals [65]. Similarly, meta-
genomic analysis showed a reduced complexity of 
Firmicutes in fecal samples from Crohn’s disease patients. 
The change of bacterial diversity has several consequences. 
First, the reduced proportion is likely compensated for by an 
increased representation of Gram negative bacteria known to 
express more proinflammatory molecules (such as 
lipopolysaccharides). Second, major groups of Firmicutes in 
the gut produce large amounts of butyrate, a metabolite that 
serves as an anti-inflammatory substance and inhibits 
cytokine mRNA expression in the mucosa [76]. Lastly, the 
loss of butyrate producers likely upsets the interaction 
between epithelial cells and gut microbe. This then 
contributes to the development of Crohn’s disease-associated 
ulcerations as well as other dysbiosis-related conditions [77].  
  These are just two examples of gut microbiota acting as 
etiological agents for gastrointestinal disorders. The 
aforementioned obesity is one condition which a pronounced 
change in microbial composition is associated with host 
pathology. Furthermore, there is indication that the 
interaction of microorganisms with one of highly expressed 
mammalian’s receptors in the adipose tissue may predispose 
the host towards type II diabetes, morbid obesity and heart 
disease [35]. The disruption of microbiota, such as caused by 
antibiotic treatment, can lead to dysregulation of host 
immune system and increase susceptibility to disease [76]. 
One notable example is antibiotic-associated diarrhea caused 
by the proliferation of Clostridium difficile resulting in 
pseudomembranous colitis, a health concern especially in 
hospitals and nursing home facilities [78, 79]. Additional 
abnormalities associated with gut microbiota have been 
demonstrated in mouse models; these include allergies, 
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d. Applications of Gut Microbiome 
  As the HMP proceeds to unravel more features of the 
intestinal microbiota and their implications, different 
applications to human and animal health are likely 
continuing to abound. One particular area that has gained 
considerable momentum is probiotics, which illustrates that 
indigenous species can be manipulated (in this case, by 
ingesting adequate amounts of beneficial bacteria) to confer 
health benefits on the host. This is based on the notion that 
probiotic organisms possess the ability to transiently 
colonize the gastrointestinal tract to allow a balance in gut 
microbiota. Mechanisms of action were deduced by clinical 
trials and they include strengthening and maintaining the 
intestinal barrier, modulating immune responses, enhancing 
microbial flora and resisting colonization by pathogens [40, 
80]. Furthermore, the metabolic products of certain probiotic 
bacteria may exert an antagonistic effect on pathogens by 
lowering pH and/or secreting antibacterial substances. 
Another proposed protective mechanism is the exclusion of 
pathogens from mucosal binding sites and nutrients by 
competing probiotic organisms, thus preventing their 
establishment in limited niches [61, 79].  
  Many microbes have been considered and tested for their 
probiotic ability. In general, species of Lactobacillus and 
Bifidobacterium are model organisms frequently utilized to 
show efficacy [72, 78, 79]. The recent advancement in 
genomics provides further insights into how probiotic 
bacteria react to the gastrointestinal tract environment. In 
fact, probiogenomics is joining systems biology to perform 
large scale analysis of probiotic bacterial genomes and to 
elucidate molecular basis of probiosis [40, 72].  
  The fact that individuals are affected by their gut 
microbiome in response to drugs has implications for 
personalized medicine and devising new approaches to drug 
discovery. In the future, gut microbiome determination may 
be considered along with Single Nucleotide Polymorphisms 
(SNPs) assessment in an individual for negative effects from 
drug metabolism (such as adverse drug interaction) [35]. The 
Consortium on Metabonomic Toxicology (COMET) has 
already considered this aspect as one of its objectives [10, 
23].  
2. Environmental Ecosystems  
  Microbial communities are an essential component of 
ecosystems. Until recently, the understanding of these 
communities was largely restricted to microorganisms that 
could be cultured [42]. The development of DNA 
sequencing technologies and novel approaches revolu-
tionized the field of environmental microbiology, allowing 
whole communities, including uncultivated members, to be 
studied [41, 45, 47, 51, 81].  
  The microbial ecosystem encompasses all 
microorganisms and their neighbors (including higher 
organisms such as plants and animals) living in a particular 
niche. The system is dynamic with various factors affecting 
the niche; these include environmental conditions (e.g., 
temperature, moisture), chemical compositions (e.g., acidity, 
nutrient concentrations) and structure of the surroundings 
(e.g., solid, fluid). Therefore, the components and 
interactions within the community range from simple (one or 
two species in a well-controlled growth condition) to 
complex (e.g., soil, ocean, rhizosphere, waste water) [42, 44, 
50, 52]. Interactions between residents are generally 
categorized as symbiotic, mutualistic or competitive.  
  Among the dynamics that result in a defined outcome are 
metabolic activities from each member. As seen in human 
gut microbiota, the community population and interactions 
have pronounced effects on the host as well as each other 
[58, 68, 77]. Thus, metabolomics plays a crucial part in 
understanding the populations and interactions within the 
microbial ecosystems. It leverages results and developments 
from the other “omics” and further provides insights into 
community functions [50, 52, 82]. Three topics are selected 
as illustrations.  
a. Biodiversity 
 Before global diversity became a Millennium 
Development Goal in the early 2000’s, microbiologists were 
already aware that prokaryotes constitute the unseen majority 
[25, 83]. Metagenomic projects from different environments 
confirmed the vast number of microbes on earth because 
population assessment is no longer impeded by the ability to 
culture them [4, 42, 48]. Large scale technologies in systems 
biology are expanding into microbial ecosystems aiming at 
understanding community functions [36, 50]. 
  The contribution of metagenomics to microbial 
community is indisputable, especially in diversity 
assessments that included uncultivated Archaea [84]. As 
highly complex communities (e.g., soil, ocean) are being 
explored, the limitations of metagenomic sequencing were 
soon realized (such as assembling numerically dominant 
species and insufficient coverage to name a few) [25, 42, 48, 
85]. Metagenomic sequencing can still serve as a hypothesis-
generating tool; however, functional diversity stemming 
from microbial diversity encompasses a wide range of 
metabolic activities. Therefore, new approaches are 
necessary to circumvent the limitations posed by 
metagenomic analysis. This is especially critical when 
assessing uncultured members of the community [50, 84].  
  Recent progress has been made in this respect. One paper 
reported utilizing fragmented genomic data to predict the 
encoded proteins, instead of relying on the types of microbes 
that produce them, to determine functions and features of the 
community [42]. When operons from several different types 
of environmental samples were analyzed, results indicated 
correlations with specific environmental conditions (soil 
versus ocean) which were reflective of metabolic demands. 
Thus, predicted meta-proteomics from genomic data paved 
the way for functional studies in microbial community [42].  
  To address metabolic capabilities and ecological 
functions among the uncultured members of the community, 
Stepanauskas and Sieracki devised an alternative to 
metagenomic sequencing [85]. Instead of using 
environmental DNA extracts, the authors sequenced multiple 
genes from individual bacterial cells and assess these genes 
in members of the community. This approach was shown to 
be more productive in metabolic mapping of uncultured 
microorganisms because their metabolic genes could be 
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in significant biogeochemical functions in marine 
environment such as photometabolic systems, nitrogen 
fixation and nitrate utilization. The results also proposed 
major carriers of certain metabolic pathways in this marine 
ecosystem [85].  
b. Metabolic Cooperation 
  Microorganisms interact in different ways to benefit each 
other within a community. Metabolic cooperation is one of 
them, and it is achieved by synergistic relationship or mutual 
exchange of metabolites [50]. The former is a simpler 
association and involves two microorganisms (i.e., co-
culture) transferring intermediate metabolites from one 
member to another. For example, Acetobacterium woodii 
and  Methanosarcina barkeri interact cooperatively to 
degrade glucose via acetate and form methane as the end 
product. This type of synergistic relationship, or syntrophic 
association, is beneficial because it is energy-efficient and 
allows maximum utilization of available resources [86].  
  Mutual exchange of metabolites is another cooperative 
approach and it can occur in biogeochemical cycling of 
nutrients and elements or breaking down of complex 
polymers by multiple organisms. During these processes, 
different members participate in complementary pathways 
and the metabolites generated are being transported in and 
out of the cell. The community structures are often 
complicated and the populations vary over time [50]. 
  Co-dependence has also been noted among members of 
the human microbiota. Different metabolite production and 
utilization pathways take place to provide nutrients or 
secondary metabolites for energy. Other members remove 
waste products by metabolizing them as energy sources and 
thus prevent toxic build up. These metabolic interactions 
contribute to homeostasis in the intestinal system [76].  
  Cooperative interactions can be inferred by analyzing the 
genomic contents of the community. For instance, taxon 
occurrence patterns in a certain ecological niche could 
provide insights of metabolic cooperation [50]. As more 
complete genomes are becoming available, metabolite 
exchanges between these members can be hypothesized. 
Furthermore, different computational tools enable metabolic 
cooperation models to be built from genomic and proteomic 
data. These objectives are generally accomplished by 
metagenomics projects. 
  On the other hand, large scale proteomics can step in if 
community genomic data is not available. One such example 
is the reconstruction of community structure and metabolism 
from a natural biofilm at an acid mine drainage site [36, 82]. 
As a self-contained environment, a mixture of Bacteria and 
Archaea carry out biogeochemical activities [81]. The 
genomes of five predominant members were reconstructed, 
ranging from near completion to partial recovery of their 
genomes. Metabolic pathways were deduced from these 
genomic data in order to understand community interactions 
and functions. Specifically among the subjects of study were 
carbon and nitrogen fixation pathways employed by 
Leptospirillum group II and Ferroplasma type II, their 
electron transport chain for respiration, and putative 
cellulose synthesis for their survival in biofilms. New 
discoveries were made, and among them were novel 
cytochromes and light-activated proteins to repair 
ultraviolet-damaged DNA [82].  
  A follow up study combined metabolomics with high-
throughput proteomics to investigate functional 
differentiation of Leptospirillum groups II and III co-
inhabiting the biolfilms of an acid mine drainage site[81]. 
These two species reflect ecological succession, with group 
II dominating at the earlier phase and group III showing 
predominance as the biofilm matures. Study results indicated 
strong metabolomics segregation based on organism type, 
leading the authors to conclude that evolutionary divergence 
is associated with the restructuring of cellular metabolic 
networks, which in turn may lessen competition and allow 
community members to occupy distinct niches [81].  
  These examples are good illustrations of linking 
metabolomics with genomics and/or proteomics to assess 
community functions and interactions. This is possible 
because acid mine drainage is a low complexity niche 
dominated by a small number of species with limited genetic 
exchanges [36, 82]. 
c. Cell to Cell Signaling 
  As microbial communities become more complex, a 
global systems approach is necessary to understand the 
formation of consortia, communication between members 
and functional interaction in a dynamic setting [42, 50]. One 
type of such interactions between microbes and their 
environment is cell to cell communication [86, 87]. This is 
often a cooperation strategy to sense and respond to 
chemical signals. The best example is quorum sensing which 
occurs between the same species (i.e., intra-species 
cooperation) [88]. When cell density is high, bacteria secrete 
small molecules (or autoducers) to initiate collective 
behaviors. These include formation of biofilms, 
bioluminescence, expression of virulence, coordination of 
enzyme expressions, and establishment of competence for 
DNA exchange [50, 86-88]. By synchronizing the behaviors 
of all members in the group, they act like a multi-cellular 
organism. One of the most studied model organisms for cell 
to cell communication is the fruiting body formation of a soil 
bacterium, Myxobacter xanthum [86, 87]. Other models for 
signaling pathways have been reported for pathogens (e.g., 
Pseudomonas aeruginosa,  Vibrio cholerae), cyanobacteria 
(e.g.,  Anabaena) and eukaryotes (e.g., Dictyostelium, 
Saccharomyces) [88].  
  Inter-species cooperation is less understood except that 
interactions are likely to be mutually beneficial. Various 
systems containing large consortia of different organisms 
have been found with implications in health care (e.g., 
biofilms on human teeth, organs) and agriculture (e.g., root 
nodules of crops) [87, 88]. Communication exists to adjust 
group behaviors and population densities in order to provide 
shelter, forage, reproduce and disperse members [86].  
  This brief discussion on cell to cell communication is 
rather simplistic. In reality, dialogues exist in microbial 
communities ranging from one- way, two- way to multi- way 
interactions. Messages are not always friendly but can be 
mixed, interfering and antagonistic [87]. Currently, 
reconstruct various inter-species small molecules produced 
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foreseeable that signaling cascades driving social behavior in 
environments can be deduced by data generated from 
components of systems biology, including metabolomics 
[50]. Data from metagenomics can again spearhead the 
discovery of novel biosynthetic pathways and from which 
small molecules exhibiting signaling activity may be inferred 
[87].  
d. Applications 
  As of July 2011, over 240 metagenomic projects have 
been completed [4]. The informatics generated from these 
data sets is invaluable; however, they represent only a 
component of ecosystems biology. The time has come to 
combine environmental microbiolomics approach with data 
from metagenomics, meta-transcriptomics and meta-
proteomics to reconstruct microbial ecosystems and 
understand their parts and connectivity.  
  They are many applications for a system-wide approach 
to assess ecosystems. Among them is utilizing metabolomics 
to understand the dynamics and interactions of intrinsic 
bioremediation that takes place in various environments. The 
Deepwater Horizon blowout in the Gulf of Mexico in 2010 
serves as a good illustration for such an opportunity. 
Scientists were pleasantly surprised to discover the 
hydrocarbon biodegradation was proceeding faster than 
expected [89, 90]. Similar to other environmental studies, 
microbial community composition and structure respond 
directly to a change in condition; in this case, the change is a 
dispersed oil plume. Genomics analysis identified –
Proteobacteria as the dominant deep-sea indigenous microbe 
responsible for hydrocarbon degradation. This led the 
authors to speculate that intrinsic bioremediation of oil 
contaminants probably exists in the deep sea [90]. 
Approximately three months later, the microbial community 
changed drastically with members of the previously 
identified hydrocarbon-oxidizers diminished significantly. 
Instead, methylotrophs and methanotrophs responded 
actively to the large scale influx of methane and converting it 
to CO2 [89].  
  These groups of bacteria represent just a small fraction of 
the deep sea microbial community adapted to this extreme 
environment. A systems approach to elucidate the dynamic 
interactions and functions of this unique habitat will have 
relevance in bioremediation, carbon cycling, metabolic 
networking and climate change.  
  Biogeochemical conversion of organic matter in the 
ocean is another area that microbial metabolomics can make 
an impact. Referred to as the biological pump, a series of 
processes starting with CO2 fixation followed by the transfer 
of organic matter to the ocean resulted in either temporary or 
permanent carbon storage. Microorganisms are capable of 
mineralizing both particulate and dissolved organic 
materials. Some of the dissolved organic materials are 
recalcitrant and persist in the ocean for a long time, thus 
becoming a reservoir of carbon storage in the ocean and 
making an impact on climate change [52].  
  The association of microorganisms and recalcitrant 
dissolved organic matter is not well understood. Since the 
biogeochemical interaction is highly complex, it is likely to 
involve multiple phases. Conceptual framework and 
hypotheses can be built on knowledge and data from systems 
biology. Microbial metabolomics serves as a crucial link for 
such understanding because recalcitrant carbon cycling is 
intimately connected with microbial processes [52].  
3. Microbial Metabolism Reconstruction 
  This review concludes with an exciting prospective for 
systems biology – the reconstruction and analysis of 
microbial metabolism. A paradigm shift has taken place 
because of the knowledge gained in post genomic era. The 
unidirectional flow of biological information from genes to 
proteins is now being reevaluated. The central dogma of 
molecular biology accepted for decades is replaced by 
dynamic interactions (e.g., feedback loops) and multiple 
connections between metabolites in cellular processing [7]. 
This results from the recognition that metabolic networks are 
complex, consisting of biochemical reactions and associated 
molecular components such as enzymes, substrates, 
products, cofactors [22, 27, 91]. As mentioned previously, 
metabolomics complements transcriptomics and proteomics 
with added value. Generated from expressions and changes 
of systems biology components, metabolomes are situated 
more downstream of the hierarchical functional analyses. 
Therefore, it more accurately reflects microbial phenotypes. 
Elucidation of cellular networks requires inputs from 
metabolomics because metabolic fluxes and interactions 
cannot be calculated or deduced from transcripts and 
proteins alone [7].  
  Reconstruction of metabolic networks to analyze cellular 
processes can be conducted by large sets of “omics”-related 
data combined with a number of computational methods and 
tools [22, 57]. Indeed, metabolic network reconstructions 
and models at a genome scale have been accomplished with 
different microorganism, even for those with only scarce 
information in the literature [31, 57]. The systematic process 
of reconstructing a metabolic network generally commences 
with an annotated genome and concludes with a predictive 
model of microbial physiology [91]. All systems biology 
components have inputs into the reconstruction of metabolic 
pathways, and various networks help refine and expand the 
metabolic content [7, 27]. Procedures involved in this 
process utilize automation analysis coupled with manual 
curation to address gaps and reconcile known metabolic 
functions with genetic and biochemical data [31, 32].  
  Furthermore, recent advances in technologies enable 
metabolite profiling which adds another dimension to 
biochemical pathways [6, 22]. A complete inventory of 
metabolomes can now be achieved by high-throughput mass 
spectrometry with platforms capable of high accuracy 
resolution [7, 9, 38]. Thus, novel metabolites can be 
discovered and followed by metabolic correlation analysis to 
infer biochemical connectivity. The predicted network is 
further validated by phenotype experiments under different 
growth conditions [22, 32]. This integrated approach 
accommodates studies of metabolic pathways that are 
peripheral albeit important players in microbial physiology 
[31].  
  One practical application in this arena is metabolic 
engineering. Microorganisms are prime candidates for 
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pollutant degradation to renewable energy [7, 22]. Rather 
than rationally altering an organism via  genetic 
manipulations to achieve enhanced performance, a holistic 
understanding of different stages in the hierarchical 
organization (from genome to metabolome) enables 
biological systems to be designed and controlled more 
accurately [27]. Global information generated from the 
“omics” as well as pre-existing knowledge of microbial 
physiology are integrated by mathematical and statistical 
methods which in turn are used to build predictive models. 
Any disparities are resolved and the models are further 
refined by experimental observations in an iterative manner 
[22, 27]. This continuous and repetitious cycle of 
perturbation biology is key to the systems biology approach 
and it is especially effective in constructing models of 
metabolic networks and dynamic interactions between the 
biological components [26]. 
  A wealth of annotation tools, software and databases 
greatly facilitate the reconstruction and model processes. 
Newly developed computational tool boxes continue to 
appear in the literature for consideration [22, 31, 32, 54, 92]. 
As a result, structured knowledge bases integrating vast 
amounts of data, databases and network reactions into one 
resource with standard nomenclature for comparison 
becomes a critical need for metabolic reconstruction and 
models. The establishment of the biochemical, genomic and 
genetic (BiGG) knowledge base serves as a metabolic model 
repository and satisfies such a need [22, 57]. Currently, 
BiGG makes available the reconstructions of genome scale 
metabolic networks from six organisms spanning three major 
branches of the Tree of Life. Among them are E. coli (a 
model organism), Helicobacter pylori (Gram negative 
bacterium),  Staphylococcus aureus (Gram positive 
bacterium) and Methanosarcina barkeri (archaea).  This 
knowledge base fulfills one of the necessities in systems 
biology: the access to a curated collection of metabolic 
models and reconstructions operating within the Constraint 
Based Reconstruction and Analysis (COBRA) framework. 
Another resource that integrates metabolic data is the 
MetaCyc database containing highly curated small molecule 
metabolites [55]. Because the metabolic pathways and 
enzyme data in this database have been demonstrated 
experimentally, it serves as a reference to general 
metabolism. The MetaCychas collected more than 1,400 
pathways from all domains of life [55]. Among the 
prokaryotes, the Proteobacteria led the number of pathways 
(750 in total). 
 The  de novo reconstruction of metabolic maps by 
genome annotation and computational predictions worked 
well for a number of organisms. Nonetheless, there are 
limitations in addressing gaps. One major obstacle is the 
unknown sequences for enzymes involved in certain 
metabolic activities [7, 22]. These orphan reactions can be 
global in nature and account for up to 30-40% of the known 
metabolic activities [7, 32]. The BiGG knowledge base can 
provide part of the solution as shown in E. coli [57]. Another 
knowledge gap concerns the unknown metabolic reactions 
and/or pathways frequently missed by automatic 
reconstruction methods. Especially critical are those not 
essential for survival (such as those only expressed under 
specific environmental conditions) and thus tend to fall 
outside the scope of network reconstruction and analysis 
[32]. The integrated approach that incorporates metabolite 
profiling addresses some of these issues [6, 22]. 
  Metabolic reconstruction can take another perspective 
and look beyond biochemical processes and networks in one 
organism for a more global overview of biochemical 
reactions involved in central metabolic pathways (such as 
carbon and nitrogen utilization). Deduced metabolism 
models for four intracellular pathogens are good examples in 
this regard [91]. In general, the carbon metabolism seemed to 
be flexible and allowing alternative substrates to be utilized. 
On the other hand, each organism showed unique 
adaptations in response to nutrient supplied by the host. 
These pathogen-specific adjustments may have a role in 
expressing virulence factors to accommodate its intracellular 
lifestyle. Another study conducted a system-based 
comparison of metabolism between related species [53]. 
Surveying the landscape of 19 genomes of the Shewanella 
genus, the researchers systematically mapped their 
carbohydrate utilization pathways. This “sugar catabolome” 
reconstruction allowed novel functional assignments of 
previously unknown (or less defined) components of 
transporters, regulators, and enzymes in different species. 
Additionally, 17 peripheral sugar catabolic pathways were 
elucidated and compared with the genomes to better 
understand the physiology and adaptation of Shewanella in 
specific environmental conditions [53]. It is foreseeable this 
type of “Genomic Encyclopedia” for a certain substrate 
utilization pathway can be reconstructed from different 
groups of microorganisms, thus expanding knowledge-based 
repositories to further the understanding of systems 
microbiology.  
  The reconstruction and modeling of microbial 
metabolism are complicated processes that involve repetitive 
steps and expertise evaluations. This short synopsis is not 
intended to delineate various approaches, but to bring 
awareness of the great potential metabolomics exerts in this 
burgeoning field and leave the details to many good reviews 
available in the literature. 
SUMMARY 
  Selected websites useful for microbial metabolomics 
research are included in the following table. Most of them 
have been mentioned in this article. These are intended as 
representative of the vast amount of resources currently 
available to the scientific community.  
CONCLUSION 
  The next decade of genomics will continue to emphasize 
function analyses and promote a systematic and integrated 
approach for life science studies. Microbiological research 
has already adopted this perspective, yielding results and 
insights not possible with traditional methodology. Microbes 
are no longer regarded as isolated organisms existing in a 
system, but rather an integrated component for 
understanding functional biology [32, 57].  
  In this review, selected topics in microbial metabolomics 
were discussed in relation to human and environmental 
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foundation of biochemical pathway deduction for decades, 
and only recently was global reconstruction and evaluation 
of cellular processes made possible by informatics input 
from systems biology as mentioned in the last section. 
Although the focus was on microorganisms, prokaryotes 
constituted the majority of the discussion. Others, such as 
viromes, are not included because they are relatively 
understudied at this time. Nonetheless, their impacts on 
various ecosystems are increasingly being recognized [93].  
  As a relatively new discipline, microbial metabolomics is 
not without trials and setbacks. It is hoped that the 
knowledge gained from other “omics” will smooth the path 
forward. Indeed, challenges such as standardization, 
metabolic annotation, measurements of metabolite flux, 
dynamic range and depth-of-coverage, as well as large 
amounts of informatics and databases have been identified 
and solutions proposed in conferences, working groups and 
publications [7, 14, 22, 25, 33, 35, 94]. Efficient 
interdisciplinary collaboration is paramount to the 
advancement of systems biology. The Human Microbiome 
Project sets a good precedence, and the recent establishment 
of Systems Biology Program for Infectious Disease Research 
sponsored by National Institute of Allergy and Infectious 
Disease (NIAID) is another innovative paradigm to address 
obstacles in pathogen and host interaction research [26]. 
Societies of metabolomics with members representing 
different areas of expertise testify to the effectiveness of 
collaboration and sharing of knowledge. Since systems 
biology represents a paradigm shift and utilizes an integrated 
approach very different from traditional studies, it will take 
some time before moving from technology and computation-
driven research to comprehensively understanding the data 
and their implications. Metabolomics research is now 
evident in academia, industry and government with more 
than 500 papers published on this subject annually. Hence, it 
is imminent that microbial metabolomics will soon join the 
rank and makes its mark in systems microbiology.  
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